Curis

CRIS · NASDAQ

$0.3996+$0.0256 (+6.84%)TodayMarket closed ·
Prev close $0.374

Latest news

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings

  • Press releasePRNewswire

    Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

  • NewsAvi Kapoor

    Why Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releasePRNewswire

    Curis, Inc. Announces Pricing of $5.6 Million Public Offering

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releasePRNewswire

    Curis Doses First Five Patients in TakeAim CLL Study

  • NewsVandana Singh

    Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

  • NewsVandana Singh

    Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates

  • Press releasePRNewswire

    Curis Announces Positive Emavusertib Update

  • Press releasePRNewswire

    Curis Consents First Six Patients in TakeAim CLL Study

  • NewsMohd Haider

    Why Did Curis (CRIS) Stock Soar After Hours?

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releasePRNewswire

    Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    Curis Reports Q1 2026 Results: Full Earnings Call Transcript

  • Press releasePRNewswire

    Curis Provides First Quarter 2026 Business Update

  • Press releasePRNewswire

    Curis Provides Fourth Quarter 2025 Business Update

  • Press releasePRNewswire

    Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

  • Press releasePRNewswire

    Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

  • NewsAvi Kapoor

    Crude Oil Down 2%; ISM Services PMI Surges In December

  • NewsAvi Kapoor

    US Stocks Edge Higher; UniFirst Shares Fall After Q1 Results

  • Press releasePRNewswire

    Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

  • Press releasePRNewswire

    Curis Provides Updated Data from its Frontline AML Triplet Study

  • Press releasePRNewswire

    Curis to Present at Upcoming 30th Annual SNO Meeting

  • Press releasePRNewswire

    Curis Provides Third Quarter 2025 Business Update

  • News

    Earnings Scheduled For November 6, 2025

  • Press releasePRNewswire

    Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

  • Press releasePRNewswire

    Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  • Press releasePRNewswire

    Curis to Present at Upcoming Healthcare Conferences in September

  • Press releasePRNewswire

    Curis Provides Second Quarter 2025 Business Update

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.